November 30, 2018
Duke spin-out Phitonex closes on $175K debt raise
Phitonex Inc., a Duke spin-out developing the next generation of fluorescent labels and instrumentation to advance the fight against disease, has raised $175,000 in a debt offering, according to a filing with the U.S. Securities and Exchange Commission.
Phitonex reagents provide a cost-effective, non-destructive method in obtaining more information about critical molecular biomarkers, simplifying experimental design and accelerating the discovery process, according to its web site.
The company is now developing two product lines: a suite of extraordinarily bright labels spanning the entire visible spectrum, and a new class of fluorescent labels and instrumentation that together increase the number of simultaneously observable molecular biomarkers by 5-10 times that of existing high channel count systems.